-transparent.png){kind=logo}
Mesna (2-mercapto-ethane sulfonic acid sodium salt) is used as a reliably acting uroprotector in cancer chemotherapy with oxazaphosphorine cytostatics. 1H-, 13C[1H]- and C,H-COSY-NMR-spectra are analyzed. In solution state mesna exists predominantly in a trans-rotameric form. These findings are supported by hypothetical gas-phase-structures of mesna, simulated via the program system MOPAC.
Related Publications
G Hägele, and
M Batz, and
R Peters, and
U Niemeyer, and
J Engel
June 2022,
The journal of physical chemistry letters,
G Hägele, and
M Batz, and
R Peters, and
U Niemeyer, and
J Engel
January 1984,
Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie,
G Hägele, and
M Batz, and
R Peters, and
U Niemeyer, and
J Engel
January 1966,
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
G Hägele, and
M Batz, and
R Peters, and
U Niemeyer, and
J Engel
September 1962,
Biochemistry,
G Hägele, and
M Batz, and
R Peters, and
U Niemeyer, and
J Engel
July 1987,
Biochimica et biophysica acta,
G Hägele, and
M Batz, and
R Peters, and
U Niemeyer, and
J Engel
June 1993,
Steroids,
G Hägele, and
M Batz, and
R Peters, and
U Niemeyer, and
J Engel
March 1967,
Chemical & pharmaceutical bulletin,
G Hägele, and
M Batz, and
R Peters, and
U Niemeyer, and
J Engel
February 1966,
Journal of pharmaceutical sciences,
G Hägele, and
M Batz, and
R Peters, and
U Niemeyer, and
J Engel
September 1968,
Journal of the American Chemical Society,
G Hägele, and
M Batz, and
R Peters, and
U Niemeyer, and
J Engel
January 1994,
Methods in enzymology,
